These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9413090)

  • 1. Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge.
    Tsarev SA; Tsareva TS; Emerson SU; Govindarajan S; Shapiro M; Gerin JL; Purcell RH
    Vaccine; 1997 Dec; 15(17-18):1834-8. PubMed ID: 9413090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and protective efficacy in rhesus monkeys of a recombinant ORF2 protein from hepatitis E virus genotype 4.
    Huang WJ; Zhang HY; Harrison TJ; Lan HY; Huang GY; Wang YC
    Arch Virol; 2009; 154(3):481-8. PubMed ID: 19240977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant vaccine against hepatitis E: duration of protective immunity in rhesus macaques.
    Zhang M; Emerson SU; Nguyen H; Engle R; Govindarajan S; Blackwelder WC; Gerin J; Purcell RH
    Vaccine; 2002 Sep; 20(27-28):3285-91. PubMed ID: 12213398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA vaccination against hepatitis E virus infection in cynomolgus macaques.
    Kamili S; Spelbring J; Krawczynski K
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl 3():S365-9. PubMed ID: 12472965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells.
    Zhang M; Emerson SU; Nguyen H; Engle RE; Govindarajan S; Gerin JL; Purcell RH
    Vaccine; 2001 Dec; 20(5-6):853-7. PubMed ID: 11738749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes.
    Arankalle VA; Lole KS; Deshmukh TM; Srivastava S; Shaligram US
    Vaccine; 2009 Feb; 27(7):1032-9. PubMed ID: 19095027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vaccination of rhesus monkeys with recombinant antigen fragments and protection from hepatitis E virus infection].
    Ma YB; Xie TH; Zhang GM; Li CH; Dai XJ; Dai CB; Sun MS; Lu J; Bi SL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):592-5. PubMed ID: 12905686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection.
    Kamili S; Spelbring J; Carson D; Krawczynski K
    J Infect Dis; 2004 Jan; 189(2):258-64. PubMed ID: 14722891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and efficacy of a bacterially expressed HEV ORF3 peptide, assessed by experimental infection of primates.
    Ma H; Song X; Harrison TJ; Li R; Huang G; Zhang H; Kong W; Wang Y
    Arch Virol; 2009; 154(10):1641-8. PubMed ID: 19763777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary evidence that a trpE-HEV fusion protein protects cynomolgus macaques against challenge with wild-type hepatitis E virus (HEV).
    Purdy MA; McCaustland KA; Krawczynski K; Spelbring J; Reyes GR; Bradley DW
    J Med Virol; 1993 Sep; 41(1):90-4. PubMed ID: 8228944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus.
    Zhou YH; Purcell RH; Emerson SU
    Vaccine; 2005 May; 23(24):3157-65. PubMed ID: 15837215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus.
    Mazalovska M; Kouokam JC
    Viruses; 2020 Jul; 12(8):. PubMed ID: 32751441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary evidence that a hepatitis E virus (HEV) ORF2 recombinant protein protects cynomolgus macaques against challenge with wild-type HEV].
    Bi S; Lu J; Jiang L; Huang G; Pan H; Jiang Y; Zhang M; Shen X
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Mar; 16(1):31-2. PubMed ID: 11986741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The immuno-protect study of a hepatitis E virus ORF2 peptide expressed in E. coli].
    Ge S; Zhang J; Huang G; Pang S; Zhou K; Xia N
    Wei Sheng Wu Xue Bao; 2003 Feb; 43(1):35-42. PubMed ID: 16276869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine.
    Purcell RH; Nguyen H; Shapiro M; Engle RE; Govindarajan S; Blackwelder WC; Wong DC; Prieels JP; Emerson SU
    Vaccine; 2003 Jun; 21(19-20):2607-15. PubMed ID: 12744897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein.
    Schofield DJ; Glamann J; Emerson SU; Purcell RH
    J Virol; 2000 Jun; 74(12):5548-55. PubMed ID: 10823861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of cynomolgus monkeys against HEV infection by oral administration of recombinant hepatitis E virus-like particles.
    Li TC; Suzaki Y; Ami Y; Dhole TN; Miyamura T; Takeda N
    Vaccine; 2004 Jan; 22(3-4):370-7. PubMed ID: 14670318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice.
    Deshmukh TM; Lole KS; Tripathy AS; Arankalle VA
    Vaccine; 2007 May; 25(22):4350-60. PubMed ID: 17459540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates.
    Li SW; Zhang J; Li YM; Ou SH; Huang GY; He ZQ; Ge SX; Xian YL; Pang SQ; Ng MH; Xia NS
    Vaccine; 2005 Apr; 23(22):2893-901. PubMed ID: 15780738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.
    Renoux VM; Fleury MJ; Bousarghin L; Gaitan J; Sizaret PY; Touzé A; Coursaget P
    Vaccine; 2008 Dec; 26(51):6602-7. PubMed ID: 18835319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.